Record Quarter in Q3 2025
Cronos delivered another record quarter in Q3 2025, highlighting continued strength of core business and global strategy success, with robust demand across key markets.
Significant Growth in Israel
Cronos achieved record net revenue in Israel, driven by the flagship PEACE NATURALS and Lit brands. Medical patient count returned to growth in 2025, up nearly 5% year-to-date.
Spinach Brand Market Leadership
Spinach brand became #2 cannabis brand in Canada with 4.5% market share, #4 in Flower with 4.9%, and #3 in vapes with 7%. Achieved #1 position in edibles with 19.7% market share.
Improved Financial Metrics
Consolidated net revenue of $36.3 million, a 6% increase year-over-year. Gross profit and adjusted gross profit were $18.3 million, equating to a 50% gross margin, a 19 percentage point improvement from Q3 2024.
Strong Balance Sheet
Cronos maintains one of the strongest balance sheets in the industry with no debt and $824 million in cash, cash equivalents, and short-term investments.